Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated
about
Description and validation of a Markov model of survival for individuals free of cardiovascular disease that uses Framingham risk factorsCharacteristics of high risk people with cardiovascular disease in Chinese rural areas: clinical indictors, disease patterns and drug treatmentRisk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.The Framingham Heart Study's impact on global risk assessmentMeeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure?Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis)Management of High Blood Pressure in Those without Overt Cardiovascular Disease Utilising Absolute Risk Scores.Towards more effective use of decision support in clinical practice: what the guidelines for guidelines don't tell you.Measures of global risk: old versus new methods.Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk.Guidelines on preventing cardiovascular disease in clinical practice.Drugs for preventing cardiovascular disease in China.Evaluation of a systematic cardiovascular disease risk reduction strategy in primary healthcare: an exploratory study from Zhejiang, China.Prediction of coronary heart disease: a comparison between the Copenhagen risk score and the Framingham risk score applied to a Dutch population.Misleading measurements: modeling the effects of blood pressure misclassification in a United States population.
P2860
Q24796318-59A47050-C5D9-46B2-8606-B0D3CDCE0A8AQ28485196-877CF520-672B-43EA-9C41-15BF3BBCD902Q33801256-1F9ABF23-1821-487C-8A19-9B619077917BQ33996738-419C3229-E406-45A3-898A-55C0F68B85A8Q34220479-CAF893DE-47A7-45C4-81B4-7BE4CCE45A71Q34240747-FB2B12ED-DCF8-4E4D-A9A3-3B26F131C05AQ35072398-ED11844F-0072-463C-B89F-436E44EA9D2EQ35866150-83473596-1572-4C7A-9D6C-0BC3E8674FC0Q36035823-74E80D9A-2C69-4B73-BC2B-3A726421AD3CQ37331446-EE18B709-5A83-4B86-B328-76D0AFA53A0AQ42766542-C3E4C14D-53A0-417A-8C53-69B0367E8984Q42973851-48F3F7ED-E176-472B-A2D3-A7FBFE4E68B7Q44197079-8A3F0CE5-B864-486F-A406-826A0F6183ABQ44407917-9D3FC474-874D-4111-ADF5-D684C2C2334FQ51105573-B8B712A9-5939-4D2F-928C-567663A76640
P2860
Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using thresholds based on risk ...... nts averted and number treated
@en
Using thresholds based on risk ...... ts averted and number treated.
@nl
type
label
Using thresholds based on risk ...... nts averted and number treated
@en
Using thresholds based on risk ...... ts averted and number treated.
@nl
prefLabel
Using thresholds based on risk ...... nts averted and number treated
@en
Using thresholds based on risk ...... ts averted and number treated.
@nl
P2093
P2860
P356
P1433
P1476
Using thresholds based on risk ...... nts averted and number treated
@en
P2093
P2860
P304
P356
10.1136/BMJ.320.7236.680
P407
P577
2000-03-01T00:00:00Z